"Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study." by Rachana Shah

Article

Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

American Journal of Kidney Diseases

Rachana Shah
Gregory J. Matthews
Rhia Y. Shah
Catherine McLaughlin
Jing Chen
Dominic S. Raj, George Washington University
et al., et al.

Link

Document Type

Journal Article

Publication Date

8-1-2015

Inclusive Pages

266-273

DOI

10.1053/j.ajkd.2015.01.021

Keywords

Cardiovascular Diseases--blood,
Chemokine CX3CL1--blood,
Diabetes Mellitus--blood,
Metabolic Syndrome X--blood,
Myocardial Infarction--blood,
Renal Insufficiency, Chronic--blood

Disciplines

Medicine and Health Sciences

Peer Reviewed

Citation Information

Rachana Shah, Gregory J. Matthews, Rhia Y. Shah, Catherine McLaughlin, et al.. "Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study." American Journal of Kidney Diseases Vol. 66 Iss. 2 (2015)
Available at: http://works.bepress.com/gregory-matthews/19/